BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9034978)

  • 1. New perspectives for nonsteroidal antiinflammatory therapy.
    de Brum-Fernandes AJ
    J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
    [No Abstract]   [Full Text] [Related]  

  • 2. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 3. COX-2 inhibitors--is there cause for concern?
    Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
    Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
    [No Abstract]   [Full Text] [Related]  

  • 4. [New NSAIDS: COX-1, COX-2, what about them?].
    Peretz A
    Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What's in the future? New NSAIDs].
    Laufer S
    Pharm Unserer Zeit; 2002; 31(2):164-9. PubMed ID: 11977452
    [No Abstract]   [Full Text] [Related]  

  • 6. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 7. COX-1 and COX-2 inhibition: current status and future perspective.
    Greyn J; Lauwers MH; Vanlersberghe C; Camu F
    Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].
    Laudanno OM; Cesolari JA; Esnarriaga J; Flaherty P; Vada J; Guastalli G; San Miguel P; Bedini OA
    Acta Gastroenterol Latinoam; 1998; 28(3):249-55. PubMed ID: 9773153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A heterogenous drug class. NSAID: classification and spectrum of action].
    Ulbrich H; Dannhardt G
    Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
    [No Abstract]   [Full Text] [Related]  

  • 10. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
    Steinhilber D
    Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
    [No Abstract]   [Full Text] [Related]  

  • 11. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?
    Warner TD; Mitchell JA
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13371-3. PubMed ID: 12374850
    [No Abstract]   [Full Text] [Related]  

  • 13. No value in chronological classification of COX inhibitors.
    Bakhle YS
    Trends Pharmacol Sci; 2004 Jul; 25(7):348-9; author reply 349-50. PubMed ID: 15219973
    [No Abstract]   [Full Text] [Related]  

  • 14. Is there anything else we could possibly need to know about COX-2 selective inhibitor drugs?
    Davis P; Juby A; Robertson S; Richard N
    J Rheumatol; 2004 May; 31(5):847-8. PubMed ID: 15124241
    [No Abstract]   [Full Text] [Related]  

  • 15. Rational use of analgesic and antiinflammatory drugs.
    Crofford LJ
    N Engl J Med; 2001 Dec; 345(25):1844-6. PubMed ID: 11752364
    [No Abstract]   [Full Text] [Related]  

  • 16. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclooxygenase (COX) inhibitors: a comparative QSAR study.
    Garg R; Kurup A; Mekapati SB; Hansch C
    Chem Rev; 2003 Mar; 103(3):703-32. PubMed ID: 12630850
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is it safe and efficient to use nonsteroidal anti-inflammatory agent by selective reduction of prostaglandin production?].
    Kankaanranta H; Vapaatalo H
    Duodecim; 1996; 112(5):419-24. PubMed ID: 10592604
    [No Abstract]   [Full Text] [Related]  

  • 20. The classification of cyclooxygenase inhibitors.
    Lipsky LP; Abramson SB; Crofford L; Dubois RN; Simon LS; van de Putte LB
    J Rheumatol; 1998 Dec; 25(12):2298-303. PubMed ID: 9858421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.